– Reuters
One-Trick Pony Boan Biotech Files for Hong Kong IPO Into Tough Market
Key Takeaways:
Boan Biotechnology sells only one product so far and is facing stiff competition from other similar drugs
Luye Pharma bought Boan in 2020 and is taking it public at a time when markets are bearish
By Molly Wen